Analyst Ratings For Evofem Biosciences (NASDAQ:EVFM)
Today, HC Wainwright initiated coverage on Evofem Biosciences (NASDAQ:EVFM) with a Buy with a price target of $15.00.
Some recent analyst ratings include
- 3/19/2018-HC Wainwright initiated coverage with a Buy rating.
Recent Insider Trading Activity For Evofem Biosciences (NASDAQ:EVFM)
Evofem Biosciences (NASDAQ:EVFM) has insider ownership of 39.20% and institutional ownership of 1.69%.
- On 12/30/2015 Alta Partners Viii, L.P., Insider, sold 797,987 with an average share price of $1.51 per share and the total transaction amounting to $1,204,960.37.
- On 12/29/2015 Alta Partners Viii, L.P., Major Shareholder, sold 493,654 with an average share price of $1.53 per share and the total transaction amounting to $755,290.62.
- On 12/28/2015 Alta Partners Viii, L.P., Major Shareholder, sold 54,333 with an average share price of $1.59 per share and the total transaction amounting to $86,389.47.
- On 12/17/2015 Kenneth W. Locke, Insider, sold 598 with an average share price of $1.26 per share and the total transaction amounting to $753.48.
- On 12/17/2015 Susan A. Knudson, CFO, sold 1,005 with an average share price of $1.26 per share and the total transaction amounting to $1,266.30.
- On 12/15/2015 Alta Partners Viii, L.P., Major Shareholder, sold 529,261 with an average share price of $1.44 per share and the total transaction amounting to $762,135.84.
- On 11/18/2015 Kenneth W. Locke, insider, sold 6,098 with an average share price of $8.30 per share and the total transaction amounting to $50,613.40.
Recent Trading Activity for Evofem Biosciences (NASDAQ:EVFM)
Shares of Evofem Biosciences closed the previous trading session at with 6.920000076293945 shares trading hands.